BFR cycling for Can BFR Cycling Augment Strength and VO2peak

Phase-Based Progress Estimates
1
Effectiveness
1
Safety
College of Physical Therapy / George Fox University, Newberg, OR
Can BFR Cycling Augment Strength and VO2peak
BFR cycling - Other
Eligibility
18+
All Sexes
What conditions do you have?
Select

Study Summary

This study will investigate if subjects who bike at 40% of heart rate reserve (HRR) with blood flow restriction (BFR) applied to bilateral thighs for 10 minutes (at 80% limb occlusion pressure) will experience greater gains in 10 rep max for dominant lower extremity leg press, greater gains in rotator cuff strength (hand held dynamometer testing for supraspinatus and external rotators) and greater gains in VO2 peak.

Treatment Effectiveness

Effectiveness Progress

1 of 3

Other trials for Can BFR Cycling Augment Strength and VO2peak

Study Objectives

3 Primary · 0 Secondary · Reporting Duration: 6 weeks

6 weeks
10 RM unilateral leg press for the dominant lower extremity
Shoulder Strength
VO2peak

Trial Safety

Safety Progress

1 of 3

Other trials for Can BFR Cycling Augment Strength and VO2peak

Trial Design

2 Treatment Groups

Cycling without BFR
1 of 2
BFR cycling
1 of 2
Active Control
Experimental Treatment

50 Total Participants · 2 Treatment Groups

Primary Treatment: BFR cycling · No Placebo Group · N/A

BFR cycling
Other
Experimental Group · 1 Intervention: BFR cycling · Intervention Types: Other
Cycling without BFR
Other
ActiveComparator Group · 1 Intervention: Cycling without BFR · Intervention Types: Other

Trial Logistics

Trial Timeline

Approximate Timeline
Screening: ~3 weeks
Treatment: Varies
Reporting: 6 weeks
Closest Location: College of Physical Therapy / George Fox University · Newberg, OR
Photo of oregon 1Photo of oregon 2Photo of oregon 3
N/AFirst Recorded Clinical Trial
1 TrialsResearching Can BFR Cycling Augment Strength and VO2peak
0 CompletedClinical Trials

Who is running the clinical trial?

George Fox UniversityLead Sponsor
3 Previous Clinical Trials
155 Total Patients Enrolled
JASON BRUMITT, PhDPrincipal InvestigatorGeorge Fox University
1 Previous Clinical Trials
55 Total Patients Enrolled

Eligibility Criteria

Age 18+ · All Participants · 1 Total Inclusion Criteria

Mark “yes” if the following statements are true for you:

About The Reviewer

Michael Gill preview

Michael Gill - B. Sc.

First Published: October 9th, 2021

Last Reviewed: August 12th, 2022

Michael Gill holds a Bachelors of Science in Integrated Science and Mathematics from McMaster University. During his degree he devoted considerable time modeling the pharmacodynamics of promising drug candidates. Since then, he has leveraged this knowledge of the investigational new drug ecosystem to help his father navigate clinical trials for multiple myeloma, an experience which prompted him to co-found Power Life Sciences: a company that helps patients access randomized controlled trials.